Immucor gets DoJ subpoena
This article was originally published in The Gray Sheet
Executive Summary
Antitrust Division of the U.S. Department of Justice subpoenas blood-transfusion instrument maker Immucor seeking documents dating back to September 2000 as part of an investigation into "possible violations of the federal criminal antitrust laws in the blood reagents industry," the company says. Immucor says it intends to "fully cooperate with the investigation." The company, which sells reagents and systems to hospitals, reference laboratories and donor centers to detect and identify various properties of both the cell and serum components in donated blood, reported in October 2007 that the Federal Trade Commission was investigating possible antitrust violations related to three of its acquisitions between 1996 and 1999. According to Immucor's most recent quarterly filing with the Securities and Exchange Commission on April 7, the firm has responded to FTC's request for documents and continues to cooperate (1"The Gray Sheet" Nov. 5, 2007, p. 18)